Skip to main content
. 2021 Feb 1;11(2):416–440.

Table 3.

Univariate and multivariate analyses of distant metastasis-free survival in breast cancer patients

Variables Category Univariate Multivariate


HR 95% CI P-value HR 95% CI P-value
Age (Years) > 35 vs. ≤ 35 0.972 0.389-2.434 0.952
Tumor size T2, T3 vs. T1 1.954 0.936-4.083 0.075 1.005 0.634-1.960 0.725
Histological grade Grade 3 vs. grade 1, 2 1.270 0.518-3.132 0.607
ER Negative vs. positive 1.775 1.079-2.941 0.025 1.443 0.862-2.387 0.166
PR Negative vs. positive 1.806 1.194-3.007 0.007 1.107 0.589-1.752 0.640
HER2 Positive vs. negative 1.651 0.827-3.304 0.157
Lymph node metastasis Positive vs. negative 4.017 2.209-7.303 < 0.001 3.543 1.939-6.440 < 0.001
TNM stage III vs. I + II 2.521 1.146-5.541 0.021 2.244 1.018-4.944 0.450
Ki-67 status > 20% vs. ≤ 20% 1.277 0.736-2.213 0.385
P53 status Positive vs. negative 0.714 0.165-3.014 0.656
YEATS4 Positive vs. negative 1.892 1.137-3.188 0.015 1.784 1.061-3.002 0.029

ER, estrogen receptor; PR, progesterone receptor; HER2, human epidermal growth factor receptor 2; TNM, tumor-node-metastasis; YEATS4, YEATS domain-containing protein 4. P-values that reach significance are in bold.